Security Snapshot

Guardant Health, Inc. - COMMON STOCK (GH) Institutional Ownership

CUSIP: 40131M109

13F Institutional Holders and Ownership History from Q4 2018 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

592

Shares (Excl. Options)

133,895,911

Price

$150.03

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.02%
Share change
-930,775
Value change
-$20,898,326
Number of holders
592
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
132,955,673
SEC-reported price per share
$161.99
Insider filing price
$161.99
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • GH - Guardant Health, Inc. - COMMON STOCK is tracked under CUSIP 40131M109.
  • 592 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 485 to 592 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $12,499,759,453 to $20,014,831,161.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 592 institutions filings for Q2 2026.

Open SEC evidence

Security key

40131M109

Latest holder period

Q2 2026

13F holders

592

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
GH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 5.2% -29% $1,034,495,258 -$359,103,556 6,895,256 -26% BlackRock, Inc. 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC 5% $608,662,324 6,589,394 Vanguard Capital Management 31 Mar 2026
PRICE T ROWE ASSOCIATES INC /MD/ 4.9% -10% $1,017,420,689 -$81,355,668 6,514,828 -7.4% T. Rowe Price Associates, Inc. 30 Jun 2026
Deep Track Capital, LP 4.4% $269,627,501 5,443,721 Deep Track Capital, LP 31 Mar 2025
CADIAN CAPITAL MANAGEMENT, LP 4.2% $258,624,114 5,221,565 Cadian Capital Management, LP 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 3.9% $240,233,923 4,850,271 Wellington Management Group LLP 31 Dec 2024

As of 30 Jun 2026, 592 institutional investors reported holding 133,895,911 shares of Guardant Health, Inc. - COMMON STOCK (GH). This represents 101% of the company’s total 132,955,673 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
61%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 5.7% 7,622,935 -34% 0.02% $1,143,668,884
PRICE T ROWE ASSOCIATES INC /MD/ 4.9% 6,514,952 -7.2% 0.1% $977,439,000
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 5,755,857 +2.3% 0.02% $863,551,226
FMR LLC 4.1% 5,488,272 +33% 0.04% $823,405,377
VANGUARD PORTFOLIO MANAGEMENT LLC 4.1% 5,445,785 -6.7% 0.04% $817,031,123
Invesco Ltd. 3.3% 4,429,755 -10% 0.05% $664,596,076
GOLDMAN SACHS GROUP INC 2.8% 3,775,895 -15% 0.06% $566,497,632
TWO SIGMA INVESTMENTS, LP 2.8% 3,719,301 -12% 0.42% $558,006,729
Capital International Investors 2.6% 3,399,604 -2.3% 0.11% $510,042,588
Deep Track Capital, LP 2.6% 3,393,312 +1.6% 7.5% $509,098,599
FRANKLIN RESOURCES INC 2.4% 3,236,065 -6.2% 0.11% $485,506,884
AMERIPRISE FINANCIAL INC 2.4% 3,150,897 +123% 0.1% $472,778,324
FULLER & THALER ASSET MANAGEMENT, INC. 2% 2,629,007 +3.1% 1.1% $394,429,884
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,521,596 -28% 0.02% $378,414,350
BAILLIE GIFFORD & CO 1.7% 2,284,127 -41% 0.31% $342,687,575
STATE STREET CORP 1.7% 2,263,504 -22% 0.01% $339,615,598
FEDERATED HERMES, INC. 1.5% 1,999,178 +5.9% 0.43% $299,936,675
EVENTIDE ASSET MANAGEMENT, LLC 1.5% 1,957,828 -17% 3.9% $293,792,955
LORD, ABBETT & CO. LLC 1.4% 1,813,491 -4.5% 0.78% $272,078,000
JANE STREET GROUP, LLC 1.3% 1,783,444 +37032% 0.17% $267,570,103
WESTFIELD CAPITAL MANAGEMENT CO LP 1.2% 1,624,459 +19% 0.8% $243,717,584
MILLENNIUM MANAGEMENT LLC 1.2% 1,622,458 +76% 0.16% $243,417,374
NORGES BANK 1.2% 1,548,518 0.02% $232,324,156
Driehaus Capital Management LLC 1.2% 1,533,985 +0.64% 1.3% $230,143,770
RTW INVESTMENTS, LP 1.1% 1,481,033 0% 1.9% $222,199,381

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
31
Latest
Q2 2026
Rows shown
1-25 of 31
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 133,895,911 $20,014,831,161 -$20,898,326 $150.03 592
2026 Q1 135,246,010 $12,499,759,453 +$298,267,788 $92.37 485
2025 Q4 131,065,980 $13,385,790,385 +$814,528,444 $102.14 495
2025 Q3 122,493,323 $7,653,044,062 -$62,866,800 $62.48 388
2025 Q2 124,295,969 $6,467,826,507 +$330,760,770 $52.04 359
2025 Q1 118,497,703 $5,048,168,027 +$16,046,986 $42.60 336
2024 Q4 119,495,658 $3,649,677,643 -$152,886,448 $30.55 294
2024 Q3 124,539,664 $2,855,453,478 +$192,800,636 $22.94 264
2024 Q2 114,848,348 $3,316,872,682 +$179,592,491 $28.88 274
2024 Q1 111,383,571 $2,296,334,142 -$29,707,645 $20.63 252
2023 Q4 110,309,454 $2,983,894,470 +$45,961,733 $27.05 289
2023 Q3 108,297,993 $3,210,080,906 -$83,646,730 $29.64 289
2023 Q2 110,144,879 $3,943,258,288 +$694,610,966 $35.80 293
2023 Q1 92,579,337 $2,168,850,990 -$17,004,713 $23.44 271
2022 Q4 94,289,245 $2,564,763,814 -$199,503,944 $27.20 280
2022 Q3 94,962,606 $5,108,852,818 +$162,272,236 $53.83 310
2022 Q2 92,768,225 $3,745,003,930 -$39,996,274 $40.34 310
2022 Q1 92,443,619 $6,110,748,734 -$81,915,249 $66.24 335
2021 Q4 92,085,897 $9,209,883,362 -$251,467,115 $100.02 379
2021 Q3 94,130,065 $11,765,302,482 +$583,304,963 $125.01 365
2021 Q2 89,577,134 $11,124,047,648 -$275,498,694 $124.19 410
2021 Q1 91,351,911 $13,941,648,366 +$681,296,473 $152.65 410
2020 Q4 87,374,557 $11,260,127,731 +$219,249,861 $128.88 399
2020 Q3 85,443,260 $9,550,543,816 +$176,117,596 $111.78 341
2020 Q2 84,323,375 $6,840,933,865 +$491,051,528 $81.13 311
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .